ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 22

$512K Total Retail Price of All Prescriptions

Rank: 5 out of 22

499 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 499 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 499 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,424 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 728 728 1 1
LISINOPRIL 465 465 2 2
SIMVASTATIN 465 465 2 3
FUROSEMIDE 290 290 4 4
OMEPRAZOLE 289 289 5 6
CITALOPRAM HBR 280 280 6 10
METOPROLOL TARTRATE 268 268 7 7
WARFARIN SODIUM 222 222 8 8
DONEPEZIL HCL 220 220 9 9
TRAMADOL HCL 201 200 10 22
NAMENDA 193 193 11 17
AMLODIPINE BESYLATE 193 193 11 5
POTASSIUM CHLORIDE 173 173 13 13
PANTOPRAZOLE SODIUM 163 163 14 29
ATENOLOL 157 157 15 12
METFORMIN HCL 156 156 16 11
GABAPENTIN 142 142 17 14
TRAZODONE HCL 139 139 18 18
HYDROCHLOROTHIAZIDE 130 129 19 15
METOPROLOL SUCCINATE 129 129 20 19
HYDRALAZINE HCL 127 127 21 60
LOVASTATIN 126 126 22 41
ZOLPIDEM TARTRATE 121 121 23 31
QUETIAPINE FUMARATE 116 116 24 21
HYDROCODONE-ACETAMINOPHEN 114 114 S3 25 16
CLOPIDOGREL 110 110 26 34
FLUTICASONE PROPIONATE 103 101 27 42
CIPROFLOXACIN HCL 86 86 28 44
OXYCODONE-ACETAMINOPHEN 83 83 S2 29 39
MIRTAZAPINE 82 82 30 24
DIGOXIN 81 81 31 45
SERTRALINE HCL 77 77 32 20
LOSARTAN POTASSIUM 73 71 33 25
ATORVASTATIN CALCIUM 73 70 33 27
PREDNISONE 68 68 35 35
GLIPIZIDE 67 67 36 30
ALENDRONATE SODIUM 67 67 36 23
KLOR-CON M20 66 66 38 43
CYMBALTA 61 61 39 67
POLYETHYLENE GLYCOL 3350 56 56 40 55
PLAVIX 55 55 41 66
CARVEDILOL 53 53 42 38
ISOSORBIDE MONONITRATE ER 53 53 42 75
KLOR-CON M10 52 52 44 76
LYRICA 52 52 44 122
OXYBUTYNIN CHLORIDE 51 51 46 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 5, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.